首页 | 本学科首页   官方微博 | 高级检索  
     

多中心型Castleman病临床病理分析并文献复习
引用本文:张 玉1,景彩萍1,赵雪艳1,张桃桃1,霍媛媛1,张冠军2. 多中心型Castleman病临床病理分析并文献复习[J]. 现代肿瘤医学, 2018, 0(12): 1896-1899. DOI: 10.3969/j.issn.1672-4992.2018.12.023
作者姓名:张 玉1  景彩萍1  赵雪艳1  张桃桃1  霍媛媛1  张冠军2
作者单位:1.延安市人民医院病理科,陕西 延安 716000;2.西安交通大学第一附属医院病理科,陕西 西安 710061
摘    要:目的:探讨多中心型Castleman病(multiple Castleman disease,MCD)的临床表现、病理学特征、鉴别诊断、病因及治疗,并分析其预后。方法:对9例多中心型Castleman病的临床资料、病理形态学特征进行分析,并行免疫组化检测及相关文献复习。结果:9例多中心型Castleman病例中,透明血管型5例,浆细胞型2例,透明血管浆细胞混合型2例。免疫组化无特征性表现,但可辅助诊断及鉴别诊断。9例多中心型患者均有完整随访资料,经治疗后其中有1例复发,1例死于心脏疾病,其余患者症状均有所缓解。结论:多中心型Castleman病是一种少见的淋巴组织增生性疾病,临床易与其他疾病相混淆,确诊需依靠病理学检查,准确的临床分型和病理类型对患者的治疗和预后具有重要意义。

关 键 词:多中心  Castleman病  临床病理特征  免疫组化  病因

Clinicopathologic analysis of multicentric Castleman disease and review of the literature
Zhang Yu1,Jing Caiping1,Zhao Xueyan1,Zhang Taotao1,Huo Yuanyuan1,Zhang Guanjun2. Clinicopathologic analysis of multicentric Castleman disease and review of the literature[J]. Journal of Modern Oncology, 2018, 0(12): 1896-1899. DOI: 10.3969/j.issn.1672-4992.2018.12.023
Authors:Zhang Yu1  Jing Caiping1  Zhao Xueyan1  Zhang Taotao1  Huo Yuanyuan1  Zhang Guanjun2
Affiliation:1.Department of Pathology,People's Hospital of Yan'an,Shaanxi Yan'an 716000,China;2.Department of Pathology,the First Affiliated Hospital of Medical College of Xi'an Jiaotong University,Shaanxi Xi'an 710061,China.
Abstract:Objective:To investigate the clinic-pathologic features,differential diagnosis,etiology,treatment of multicentric Castleman disease,and analyze their prognosis.Methods:Retrospective analysis of the clinical features,pathological morphology,immunohistochemistry were conducted in 9 cases of multicentric Castleman disease and reviewed of literature.Results:There were 5 cases of hayline vascular types,2 cases of plasmatcyic type and 2 cases of mixed type in all multicentric Castleman disease. Immunohistochemical results had not specific change,but they can assist diagnosis and differential diagnosis.9 cases had complete follow-up data,1 case recurrened after treatment,1 case died of heart disease,other multicentric cases achieved sustained remission.Conclusion:Multicentric Castlemandisease is a rare lymphoproliferative lesion,it is easily confused with other diseases,identified diagnosis is depend on pathological examination.The accuracy of clinical subtype and histopathogenic type are important for treatment and outcome.
Keywords:multicentric   Castleman disease   clinicopathologic features   immunohistochemistry   etiology
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号